Targeted Oncology
Targeted Oncology
Targeted Oncology

The Future of Biomarkers in Prostate Cancer

Mark Stein, MD
Published Online:10:35 AM, Tue November 22, 2016

Mark Stein, MD, medical oncologist, Rutgers Cancer Institute of New Jersey, discusses the future of biomarkers in prostate cancer.
Publications